Craig Thomas

36PUBLICATIONS
291CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Nov 05, 2026
Combination Therapy with AKT and MEK Inhibitors is Effective in Patient-Derived Models of Adrenocortical Carcinoma.

|Nov 02, 2026
Kinome profiling enabled development of a LATS1/2 inhibitor with wound healing potential.

|Apr 17, 2026
Ubiquitin-dependent recruitment of SLFN11 to chromatin is regulated by deubiquitinase (DUB) and RNF168.

|Feb 11, 2026
Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.

Patience Odeniyide, Alyza Skaist, Elizabeth Fenner

|Dec 18, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.

Ana Corrionero, Xiaohu Zhang, Patricia Alfonso

|Oct 08, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancer.

Juan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo

Pageof 6

Frequent Collaborators

9 joint publications

Kelli Wilson

8 joint publications

Michele Ceribelli

7 joint publications

Xiaohu Zhang

7 joint publications

Yves Pommier